Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 35INDUSTRY 30NIH 9NETWORK 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 5Esophageal Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Small Cell Lung Carcinoma 2Pathologic Complete Response 2Fallopian Tube Neoplasms 2Adenocarcinoma of Lung 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thymoma 1Testicular Neoplasms 1Recurrence 1Ovarian Neoplasms 1Non-squamous Cell Non-Small Cell Lung Cancer 1Non-Squamous Non-Small Cell Lung Cancer 1Nasopharyngeal Carcinoma 1Lung Neoplasms 1HER2 Positive Breast Cancer 1Endometrial Neoplasms 1EGFR Positive Non-small Cell Lung Cancer 1Carcinoma, Ovarian Epithelial 1

Interventions

pembrolizumab 1dostarlimab 1Surgical Procedures, Operative 1Sentinel Lymph Node Biopsy 1Paclitaxel 1Motivational Interviewing 1Metformin 1Medroxyprogesterone Acetate 1Laparotomy 1Laparoscopy 1Indocyanine Green 1Exercise 1ETC-159 1Diet 1Cisplatin 1Carboplatin 1CP protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Endometrial Neoplasms × Carboplatin × Clear all
NCT06066216 2024-01-23

Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer

Fujian Cancer Hospital

Phase 2 Not yet recruiting
45 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡